NATCO Pharma Dividend
Dividend criteria checks 4/6
NATCO Pharma is a dividend paying company with a current yield of 0.65% that is well covered by earnings. Next payment date is on 11th September, 2024 with an ex-dividend date of 23rd August, 2024.
Key information
0.6%
Dividend yield
6%
Payout ratio
Industry average yield | 0.7% |
Next dividend pay date | 11 Sep 24 |
Ex dividend date | 23 Aug 24 |
Dividend per share | ₹9.500 |
Earnings per share | ₹91.37 |
Dividend yield forecast in 3Y | 0.3% |
Recent dividend updates
Recent updates
NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market
Aug 13If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity
Jul 15NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02NATCO Pharma's (NSE:NATCOPHARM) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 22Estimating The Intrinsic Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
Feb 16Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NATCOPHARM's dividend payments have been volatile in the past 10 years.
Growing Dividend: NATCOPHARM's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
NATCO Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NATCOPHARM) | 0.6% |
Market Bottom 25% (IN) | 0.3% |
Market Top 25% (IN) | 1.1% |
Industry Average (Pharmaceuticals) | 0.7% |
Analyst forecast in 3 Years (NATCOPHARM) | 0.3% |
Notable Dividend: NATCOPHARM's dividend (0.65%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: NATCOPHARM's dividend (0.65%) is low compared to the top 25% of dividend payers in the Indian market (1.1%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (6%), NATCOPHARM's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (20%), NATCOPHARM's dividend payments are well covered by cash flows.